Valiant Navion Voluntary Recall
In February 2021, Medtronic issued a global voluntary recall of the Medtronic Valiant Navion™ Thoracic Stent Graft System.
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Valiant Navion™ is the third and latest generation of thoracic endovascular aortic repair (TEVAR) in a single system, with covered and bare stent options.
The Valiant Navion system is designed to treat a wide range of patient anatomies and all lesions of the descending thoracic aorta (DTA), including thoracic aortic aneurysms (TAA), type B aortic dissection (TBAD), intramural hematoma (IMH), penetrating atherosclerotic ulcer (PAU), and blunt thoracic aortic injury (BTAI).